HAE Logo

Haemonetics Corporation (HAE) 

NYSE
Market Cap
$4.3B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
359 of 775
Rank in Industry
26 of 48

Largest Insider Buys in Sector

HAE Stock Price History Chart

HAE Stock Performance

About Haemonetics Corporation

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides …

Insider Activity of Haemonetics Corporation

Over the last 12 months, insiders at Haemonetics Corporation have bought $0 and sold $3.46M worth of Haemonetics Corporation stock.

On average, over the past 5 years, insiders at Haemonetics Corporation have bought $323,720 and sold $6M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 4,000 shares for transaction amount of $323,720 was made by ABERNATHY ROBERT E (director) on 2020‑08‑11.

List of Insider Buy and Sell Transactions, Haemonetics Corporation

2024-07-26SalePresident, Global Hospital
4,312
0.0085%
$91.15$393,039-16.40%
2024-07-12SaleEVP, Chief Technology Officer
79
0.0002%
$90.00$7,1100.00%
2024-07-11SaleEVP, Chief Technology Officer
2,136
0.0045%
$90.00$192,2400.00%
2024-05-29SaleEVP and General Counsel
12,990
0.0257%
$88.08$1.14M-10.70%
2024-05-29SalePresident, Global Hospital
8,857
0.0174%
$87.53$775,253-10.70%
2024-05-20SaleEVP and General Counsel
1,604
0.0032%
$95.08$152,508-16.53%
2024-05-20SaleEVP, Global Manufacturing
987
0.0019%
$95.08$93,844-16.53%
2024-05-20SalePresident, Global Hospital
686
0.0013%
$95.11$65,245-16.53%
2024-05-17SaleEVP and General Counsel
1,073
0.0021%
$95.00$101,935-16.66%
2024-05-17SaleEVP, Global Manufacturing
822
0.0016%
$94.82$77,942-16.66%
2024-05-16SaleEVP and General Counsel
985
0.002%
$96.14$94,698-15.57%
2024-05-16SaleEVP, Global Manufacturing
770
0.0015%
$96.14$74,028-15.57%
2024-05-16SalePresident, Global Hospital
733
0.0015%
$96.04$70,397-15.57%
2024-05-06SaleEVP, Chief Technology Officer
2,305
0.0045%
$95.00$218,975-12.20%
2023-09-12SalePresident, Global Hospital
228
0.0005%
$90.65$20,668-5.52%
2023-09-11SaleEVP, Chief Technology Officer
2,305
0.0045%
$90.00$207,450-6.34%
2023-09-05Saledirector
10,215
0.0202%
$87.68$895,651-2.33%
2023-07-18SaleEVP, Global Manufacturing
4,928
0.0095%
$90.00$443,520-6.13%
2023-06-07SalePresident, Global Hospital
2,538
0.005%
$88.04$223,446-2.38%
2023-05-30SaleEVP, Chief Technology Officer
2,304
0.0045%
$83.33$191,992+2.78%

Insider Historical Profitability

5.46%
Simon, ChristopherPresident & CEO
213724
0.4255%
$85.54121+13.41%
CONCANNON BRIANPresident & CEO
147040
0.2928%
$85.54857+8.69%
GELBMAN RONALD Gdirector
48384
0.0963%
$85.54116+4.67%
LINDOP CHRISTOPHER JCFO & EVP Business Development
45350
0.0903%
$85.541215+4.66%
ALLEN PETER MPresident, Global Plasma
34102
0.0679%
$85.542022+7.23%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Capital Research Global Investors$569.69M13.136.67M+2.32%+$12.9M0.13
BlackRock$510.77M11.775.98M-0.92%-$4.75M0.01
The Vanguard Group$460.66M10.625.4M-0.17%-$766,357.650.01
Wellington Management Company$364.52M8.44.27M+30.68%+$85.59M0.06
Neuberger Berman$323.28M7.453.79M+7.28%+$21.93M0.27
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.